Replies to post #657860 on NorthWest Biotherapeutics Inc (NWBO)

[norisknorewards]

Bend over, it's time....

[flipper44]

Submission means an application for approval can be decided in due course. Submission does not mean approval or rejection. Good luck (not really) with your explanation.

[dstock07734]

I repeatedly told you before that it's time for you to take a loss and bail. I presented all the facts. You can think many facts are speculations. But the following figure that I showed you again and again, which the company is so proud of since no other companies can achieve this amazing milestone in the foreseeable future, is the real data, you should know better data don't lie.

Now once again: time for you to bail.

As the Company previously reported, proteomic studies have demonstrated that a single tumor lysate sample contained tens of thousands of different peptides and, out of this pool, the dendritic cells selected, processed and presented over 600 different peptides (tumor targets) to T cells. T cell studies (TCR sequencing and T cell clonal expansion assays) analyzing the breadth and strength of T cell response following DCVax-L treatment have found extensive responses, including clonal expansion of up to 800 T cell clones at month 4 and up to 1200 T cell clones at month 8 in the samples studied. Each T cell clone focuses on a particular and distinct target. In individuals not being treated with the vaccine, only 2 – 20 new T cells clones are seen between month 4 and month 8.

The results of these proteomic, T cell and other studies provide support for what the Company believes to be the mechanism of action of DCVax-L: i.e., mobilizing a broad spectrum and strong de novo T cell response that addresses the extensive heterogeneity of GBM and overcomes the immunosuppressive microenvironment around the tumor.

[The Danish Dude]

Get lost fudder

[CaptainObvious]

Retreat and retrench.

That's the way ya do it!
Money for nothing
And your chits for free